Parexel’s Peyton Howell and Sofia Baig Named to 2021 PharmaVOICE 100
02 août 2021 08h00 HE
|
Parexel International LLC
Parexel leaders recognized as two of the 100 most inspiring people in life sciences for their transformative efforts to drive equity and innovation across the industry BOSTON and DURHAM, N.C., Aug. ...
Parexel Announces Innovative Patient Centric Partnership with Cancer Hospital Chinese Academy of Medical Sciences
28 juil. 2021 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 28, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Announces Innovative Partnership with Rare Disease Foundation in China
22 juil. 2021 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Expands Asia/Pacific Capability through Enhanced Clinical Trial Supplies and Logistics Offering
07 juil. 2021 08h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Akan Diakuisisi oleh EQT Private Equity dan Goldman Sachs Asset Management
06 juil. 2021 14h52 HE
|
Parexel International LLC
BOSTON dan DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, sebuah organisasi riset klinis global (CRO/clinical research organization) terkemuka yang berfokus pada pengembangan dan...
Parexel adquirida por EQT Private Equity y Goldman Sachs Asset Management
06 juil. 2021 14h52 HE
|
Parexel International LLC
BOSTON y DURHAM, Carolina del Norte, July 06, 2021 (GLOBE NEWSWIRE) -- Parexel, una organización líder mundial de investigación clínica (CRO) centrada en el desarrollo y entrega de nuevas terapias...
Parexel, EQT Private Equity와Goldman Sachs Asset Management가 인수
06 juil. 2021 14h52 HE
|
Parexel International LLC
보스턴, 노스캐롤라이나주 더럼, July 07, 2021 (GLOBE NEWSWIRE) -- 환자 건강 증진을 위한 혁신적인 신약 개발 및 공급에 중점을 두고 있는 글로벌 CRO(임상시험수탁기관)인 Parexel은 EQT IX 펀드(“EQT Private Equity”)와 Goldman Sachs Asset Management...
パレクセルをEQTプライベート･エクイティとゴールドマン･サックス･アセット･マネジメントが買収
06 juil. 2021 14h52 HE
|
Parexel International LLC
ボストンおよびノースカロライナ州ダーラム発, July 07, 2021 (GLOBE NEWSWIRE) -- 患者の健康を増進するために革新的な治療薬の開発･提供に注力する国際的な大手医薬品開発業務受託機関 (CRO) であるパレクセル (Parexel) は本日、最終的な合併契約締結を発表した。この契約の下、同社は (先にパレクセル株式を買収した) パンプローナ･キャピタル･マネジメント...
Parexel s'apprête à être acquise par EQT Private Equity et Goldman Sachs Asset Management
06 juil. 2021 14h52 HE
|
Parexel International LLC
BOSTON et DURHAM, Caroline du Nord, 06 juill. 2021 (GLOBE NEWSWIRE) -- Parexel, une organisation de recherche clinique (CRO) de premier plan à l'échelle mondiale axée sur le développement et la...
Parexel即将由EQT Private Equity和Goldman Sachs Asset Management收购
06 juil. 2021 14h52 HE
|
Parexel International LLC
波士顿和北卡罗来纳州达勒姆, July 07, 2021 (GLOBE NEWSWIRE) -- 专注于开发和提供创新疗法以促进患者健康的全球领先临床研究机构（CRO）Parexel今天宣布了一项最终合并协议的执行。根据该协议，EQT IX基金（“EQT Private Equity”）和Goldman Sachs Asset Management旗下私募股权业务部门（“Goldman...